The estimated base pay is $216,524 per year. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. Q: Did you experience any side effects or complications from the vaccine? Im fortunate to continue seeing patients as part of my role at Centene, so scrubbing up and practicing good hand-washing hygiene is very familiar to me as an orthopedic surgeon. Dave joined Fidelis in 1999 as Director of Strategic Planning and Development and held positions of increasing responsibility during his tenure from Vice President, Senior Vice President of Operations, Senior Vice President and Chief Administrative Officer, and Executive Vice President and Chief Operating Officer culminating in leading the organization. Previously, he was President and COO for Magellan Health where he oversaw the Magellan Behavioral and Specialty Health and Magellan Complete Care business segments. Aydanos a proteger Glassdoor verificando que eres una persona real. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. As part of her work with the Heart Association, shes participating in a Hispanic radio series, and shell be talking with her father, who is diabetic, about heart health. Centene said it net income increased 33% year-over-year, to $1.13 billion, or $2.11 earnings per share, on revenues of $38.8 billion, driven by increased exchange revenue and lower medical expenses. Brent Layton, Senior Advisor to CEO, Centene Corporation. uctuations in medical . The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. los inconvenientes que esto te pueda causar. A: My routine wont change. ST. LOUIS, April 20, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has named Anika Gardenhire RN, BSN, MMCI as its Chief Customer Experience Officer (CXO). enva un correo electrnico a CENTENE IS COMMITTED TO CORPORATE SUSTAINABILITY . ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. If we keep frontline workers safe and healthy, they can continue providing vital services for those in need without adding strain to an already overwhelmed healthcare system. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. pour nous faire part du problme. Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state's response to the COVID-19 pandemic. Alice H. Chen, MD, MPH, Chief Health Officer, Centene Corporation. We are sorry for the inconvenience. Q: How will your daily routine change post-vaccine? Join to view profile Centene-Maryland Physicians Care . ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. Brian LeClaire, Chief Information Officer, Centene Corporation. The estimated total pay for a Chief Medical Officer at Centene is $310,340 per year. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. Dave Thomas most recently served as Centene's Executive Vice President, Markets where he was responsible for the oversight of Centene's 31 health plans nationwide. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Transforming the health of the community, one person at a time. All forward-looking statements included in this press release are based on information available to us on the date hereof. Biography. "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. removing social barriers to health, and prioritizing responsible Sunshine Health Appoints Nathan Landsbaum as CEO in Florida /PRNewswire/ -- Sunshine Health, a wholly owned subsidiary of Centene Corporation, is pleased to announce the appointment of Nathan. to let us know you're having trouble. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Previously, he was President and CEO of Fidelis Care where he led oversight across all divisions of Fidelis Care. Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. A: I didnt. Since joining Centene in 2006, he has overseen the development and implementation of new health plans in more than 25 states, provided strategic guidance to state governments to help them develop effective Medicaid solutions, and developed new business contracting with providers and health systems where he led the company's effort in value-based purchasing. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Brent Layton becomes Senior Advisor to the CEO, Dave Thomas becomes Chief Executive Officer of Markets and Medicaid, Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer. Thats why it has been important for Wellcare to hold events in the community and partner with trusted community voices. When were able to bring resources to bear information and volunteers and bring them right into a neighborhood, we see people who come out who may at first just be curious, and then theyre able to communicate in the language they feel most comfortable with, and the next thing you know, theyre bringing along their families and friends, Dr. Guerra said. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality . Prior to joining HealthMarkets, Mr. Fasola spent nearly twenty years in executive leadership roles at UnitedHealth Group and Humana. He has led the successful integration of two $10+ billion health plans. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Most COVID-19 vaccines require two injections; the first starts building protection and the second is given a few weeks later. Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS, CENTENE CORPORATION NAMES ANIKA GARDENHIRE CHIEF CUSTOMER EXPERIENCE OFFICER. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Chief Executive Ocer of Centene. It gives her an opportunity to speak to the Hispanic community about a vital issue, directly discussing her familys own experiences. Part of the reason she is at Wellcare is that she believes the private sector can play an important role in improving health outcomes. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Mr. Thomas received a bachelor's degree in Sociology from the University at Albany and a Master of Business Administration from the Zicklin School of Business at Baruch College in Manhattan. Onze Mr. Layton received his bachelor's degree from the University of Georgia. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state's response to the COVID-19 pandemic. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. With extensive leadership and more than 20 years of experience in the managed care industry, Mr. Thomas will take on an expanded scope and responsibility for the Medicaid product and business development. Als u dit bericht blijft zien, stuur dan een e-mail Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de CENTENE CORP Compensation by Company Data Year: 2022 2021 2020 2019 Select Other Years For its 2022 fiscal year, CENTENE CORP, listed the following executives on its annual proxy statement to the SEC Equity Cash Compensation Other Fiscal Year Ended in 2022 Enter an executive or company name Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Transforming Communities, Health & Wellness. A: Healthcare personnel continue to be on the front line of our country's battle against COVID-19. Mr. Fasola holds a Bachelor of Science in Health Planning and Administration from Pennsylvania State University and was named an Alumni Fellow in 2010. excuses voor het ongemak. Medical professionals have sometimes stayed away from non-traditional media, Dr. Guerra said. Centene.com uses cookies. Previously, he was President and CEO of Fidelis Care where he led oversight across all divisions of Fidelis Care. Prior to joining Centene, Brian LeClaire was Director, Technology, for the healthcare team at Arsenal Capital Partners, a private equity firm specializing in investments in healthcare and industrial growth companies. Dr. Yamaguchi received a dose of the vaccine at Barnes-Jewish Hospital in St. Louis, Missouri (pictured). Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Brian LeClaire, Chief Information Officer, Centene Corporation. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's . I'm still wearing a mask, staying at least six feet away from others, and not gathering with those outside my household. removing social barriers to health, and prioritizing responsible COVID-19 Vaccination: Q&A with Centene's Chief Medical Officer, most up-to-date information on the COVID-19 vaccine. This list of important factors is not intended to be exhaustive. Learn more about Centene's commitment to diversity, equity, and inclusion and our community partnerships. and Terms and "With these appointments, Centene is aligning the outstanding talent within our senior executive team with the Company's value creation mission and long-term strategy for growth," said Centene Chief Executive Officer (CEO) Sarah London. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. Innovations & Initiatives, Health & Wellness. In March 2023, Centene announced the appointment of Tanya McNally to Senior Vice President and Chief People Officer. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Prior to that he served as CEO of UnitedHealth Care's Central Region, President of UnitedHeathcare lines of business and National Sales Officer. Forward-Looking Statements The Centers for Disease Control and Prevention (CDC) has the most up-to-date information on the COVID-19 vaccine, including clinical resources and state-related guidance. The perspective of Centene's international operations provides a better understanding of the potential domestic impact of COVID-19. verdade. Brent Layton will become Senior Advisor to the CEO, as he begins his transition towards retirement. Lamentamos pelo inconveniente. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. She also has a Master of Public Health in Health Care Management and Policy from Harvard School of Public Health. As the vaccine supply increases, vaccination will be available for additional segments of the population. Alice Hm Chen, MD, MPH, serves as Chief Health Officer (CHO) for Centene Corporation. As the COVID-19 pandemic evolves, different prevention strategies emerge, including immunization. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. As a practicing physician. Prior to that, he was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. HealthMarkets was acquired by UnitedHealth Group in 2019. Dr. Chen is responsible for Centene's strategies, policies, and programs in support of improving population health for Centene's more than 26 million members. The difference is that the private sector often has the resources to make things happen, whether thats related to addressing social determinants of health or other priorities.. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. As CHO, Dr. Chen will be responsible for Centene's strategies, policies, and programs in support of improving population health for Centene's more than 26 million members. Even after being vaccinated its important to follow all the expected CDC-recommended safety procedures. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Mr. Fasola holds a Bachelor of Science in Health Planning and Administration from Pennsylvania State University and was named an Alumni Fellow in 2010. Centene.com uses cookies. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Executive Vice President of External Affairs. Dr. Ken Yamaguchi, Centene Executive Vice President & Chief Medical Officer, has firsthand experience with the COVID-19 vaccine. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. Ken Fasola, President, Centene Corporation. Both individuals will report to Sarah London. Hispanic Heritage Month: Meet Dr. Sandra Guerra. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. 3K followers 500+ connections. LOUIS, March 22, 2022 / PRNewswire / -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. He joined Centene through the acquisition of Magellan Health Inc (MGLN) where he served as CEO and a member of the Board of Directors. Transforming the health of the community, one person at a time. Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. Mr. LeClaire received a Bachelor of the Arts in Psychology from Ripon College; a Master of Business Administration in Accounting from the University of Wisconsin, Oshkosh; and a PhD in Management Information Systems, with a minor in Computer Science, from Oklahoma State University. Our local approach allows us to help members access high-quality, culturally sensitive healthcare services. Mr. Layton most recently served as President and Chief Operating Officer for Centene Corporation where he oversaw the company's healthcare offerings, including 30 State Medicaid Health plans, the nation's largest Exchange provider, Ambetter, and the WellCare brand of Medicare products, and was a member of the Office of the CEO. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. As a practicing physician. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Chief Medical Officer, Pharmacy, Innovation Merritt Island, Florida, United States. Ken Fasola, President, Centene Corporation. In her management role, Ms. London led the Company's technology and digital strategy in addition to running the Health Care Enterprises and Specialty divisions, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management. Please help us protect Glassdoor by verifying that you're a The CDC's recommendations for individuals eligible for the initial phases of COVID-19 vaccination are below: The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. Both individuals will report to Sarah London. The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing responsible corporate governance. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. "With these appointments, Centene is aligning the outstanding talent within our senior executive team with the Company's value creation mission and long-term strategy for growth," said Centene Chief Executive Officer (CEO) Sarah London. las molestias. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Chief Health Officer. ein Mensch und keine Maschine sind. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Because of the language barrier, many Hispanic Kentuckians may have already faced health access issues, which is one of the reasons why the virus has had a disproportionate impact in this community, but Dr. Guerra has also noticed the impact that misinformation found on social media can have on compounding disparities. He joined Centene through the acquisition of Magellan Health Inc (MGLN) where he served as CEO and a member of the Board of Directors. At Humana Mr. Fasola was the COO of Market Operations and formerly a member of the Office of the Chairman, a role he assumed after thirteen years leading various divisions within the company. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.